News Diabetes wearable and VR platform winners at Healthtech Summ... Insulin delivery wearable and neuro-rehabilitation virtual reality scoop top awards.
News Abbott’s needleless diabetes platform as effective as self-m... Study demonstrates a 38% reduction in time spent in hypoglycaemia, compared to traditional self monitoring.
News Victoza disappoints on cardio benefits, lifts rival Jardianc... Victoza results are significant, but fell short of investors' expectations.
News Sanofi's diabetes combo on target for showdown with Novo Rival insulin and GLP-1 combinations under review in US.
News Pharma looking to dual-action diabetes drugs to boost sales Pharma using FDA-mandated trials to give a commercial advantage.
News Islexa promises revolutionary type 1 diabetes cell therapy A UK company has been launched with the aim of curing type 1 diabetes using groundbreaking cell therapy.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.